Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-16-024380

President and CEO sold 56,789 shares at an average $29.81 ($1,692,705)

  • President and CEO acquired 56,789 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pomerantz Roger · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2016-07-01 Exercise or conversion : show line 1 in the form +56,789 $0.71 $40,320 240,481 D
2016-07-01 Sale : show line 2 in the form −4,832 $29.12 $140,708 235,649 D
2016-07-01 Sale : show line 3 in the form −41,957 $29.84 $1,251,997 193,692 D
2016-07-01 Sale : show line 4 in the form −10,000 $30.00 $300,000 183,692 D
Open-market sales · 56,789 sh · avg $29.81 · $1,692,705

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-07-01 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −56,789 $0.71 2024-08-07 56,789 1,160,497 D
Loading xslF345X03/doc4.xml…